Australian economy looks for lift from medical marijuana
As medical marijuana gains more and more acceptance around the globe, both politicians and citizens have warmed up to the idea of cannabis for medicinal purposes.
In the U.S., Illinois will finally begin selling its first batch of medical marijuana after those in favor began pushing for it over 10 years ago. Meanwhile in New York, the state is requiring physicians to complete an unusual educational course before being able to authorize medicinal marijuana for patients.
Down in the Southern Hemisphere, Australia Federal Health Minister Sussan Ley announced the country will also join the trend by changing its legislation to allow the cultivation of cannabis for medical use by the end of this year.
While the Aussie political parties all are in favor of using marijuana for medical reasons, they all have different views on how to regulate and build the industry.
Recently, the Australian state of Victoria announced it will become the country’s first to allow and manufacture the sale of products containing the main chemical in cannabis, THC, although the state of South Australia began deciminialising low-level marijuana offenses in 1987.
The nation’s three most populated states Victoria, New South Wales and Queensland have each vowed to hold surveys on the effectiveness of medical marijuana to provide pain relief for those suffering from terminal illnesses, sleep disorders and symptoms stemming from chemotherapy in cancer patients.
States and territories in Australia are not legally allowed to grow or import cannabis for medical use. However, creating a regulatory body would take away a major obstacle in beginning the state trials, which Ley calls the “missing piece” of the process.
“Currently there are already systems in place to license the manufacture and supply of medicinal cannabis-based products in Australia, however there is no mechanism to allow the production of a safe, legal and sustainable local supply,” said Ley. “This has meant Australian patients, researchers and manufacturers have had to try to access international supplies of legal medicinal cannabis crops and products, but limited supplies and export barriers in other countries have made this difficult.
RELATED TOPIC: 3 Problems Doctors Face When Prescribing Medical Marijuana
“Allowing the cultivation of legal medicinal cannabis crops in Australia under strict controls strikes the right balance between patient access, community protection and our international obligations.”
A number of Australian state governments are anticipated to begin growing the plant if the regulation process goes through. In addition, the industry will most likely gain millions for struggling state economies, especially if Australia clears legal hurdles to export marijuana to other countries.
As an example, 45 percent of the world’s opium used in pharmaceutical painkillers is produced by the Tasmanian poppy industry, which brings in $300 million to the state each year.
Thousands of Aussie campaigners have been pushing for the law to be amended, as they believe it is unfair to criminalize patients who rely on the drug to help with pain. Since the petition on Change.org was launched two years ago, over 246,000 Australians have signed on.
Click here to read the latest edition of Healthcare Global magazine!
Women leading in healthcare means better patient outcomes
I know I’m pointing out the obvious, but women are different to men. In the context of healthcare—a woman’s physiology, symptoms and sometimes even treatment options are different from a man's. We have witnessed this in cardiovascular health, where there is ample research and evidence that women’s symptoms are often different to men’s. We also know that heart disease is responsible for 1 in 3 deaths in women annually—it is the number one killer.
The fact is women do not always get the treatment they need. A lot of that has to do with who is treating them, how they are being treated by their physicians and the healthcare systems that are designed to support patient needs.
The proof is in the research at the care level; a 2017 study of hospitalised patients over the age of 65, examined differences in outcomes based on the gender of the treating physician. The results of the study concluded that patients treated by female physicians had lower mortality and readmission rates compared with those cared for by male physicians.
Gender equity starts at the top
I believe that gender equity in healthcare starts at the top with the leaders who set expectations around workplace culture, and that trickles down to the workforce.
You might think gender has nothing to do with how patients are treated—a patient is a patient, regardless of age, ethnicity, religion, creed, color or gender. But I believe there is a correlation between female leadership in healthcare and better patient outcomes—for men and women. Despite a predominantly female workforce in healthcare (65% of healthcare workers are women), only 13% of healthcare CEOs are women.
The disparity in the number of women in the healthcare C-suite is irrefutable, but I believe the more diversity we have at the boardroom table in hospitals and health systems— and that includes women—the more perspectives we bring to the decisions that ultimately impact patients and their families.
Female healthcare leaders are also caregivers
Many women are still the primary caregivers at home. The responsibility of grocery shopping and meal planning, making doctor and dentist appointments for children and elderly parents, and everything in between still tends to fall to women.
This lived experience gives women the ability to think about innovations and solutions from the perspective of the caregiver—not just the patient. The fact is when someone is sick in the family, it affects the whole family.
As a woman, I often think about solutions and technologies that facilitate holistic healing and health that support the whole family. Bringing the mentality of inclusion to healthcare leadership means programs like the American Heart Association’s Go Red for Women campaign, will ensure research and treatment for cardiovascular disease in women will get the attention it deserves and ultimately, better outcomes for patients.
The bottom line and meaningful work are equally important
A 2019 study found that public companies with a female CEO were more profitable than their competitors with men at the helm, but that didn’t come at the cost of job fulfillment.
Women who lead companies and organisations can influence their workforce by rallying around a common cause. Having meaningful work and the opportunity to make a difference in the world is powerful motivation that doesn’t have to come at the cost of profitability.
The work we do at Abbott is a good example—I consistently reinforce the good that comes from the research and development of the products we make with my team. Clinical trials, like the current LIFE-BTK trial, is consciously recruiting female principal investigators who work with underserved populations to enroll patients from communities of color and women. Knowing the work we do has a social impact on society might be difficult to quantify, but in my opinion, it’s priceless and could lead to meaningful treatment options that improve patient outcomes in the long-term.
Emotional intelligence and empathy are not soft skills
Interpersonal skills, problem-solving and self-awareness are considered “soft skills”—skills that might not be required to do the job, but in leadership positions, they are no longer “nice to haves,” they are “need to haves” if you are going to inspire high-performing teams.
Research suggests women tend to score higher on social and emotional competencies than men. In the words of Joanne Conroy, the CEO and President of Dartmouth-Hitchcock Health in New Hampshire, “Diverse representation at the table changes the conversation. It becomes more collaborative; there is more listening and less interrupting. We have better conversations about how we are functioning as a team and we create a safe space when people can be honest with their feedback to all members of the team, including the leader.”
I’m not suggesting women have a monopoly on soft skills, however having gender diversity around the boardroom table means a diversity of skills. Being aware of your team’s morale and what motivates them is equally important as managing your supply chain.
When it comes to health, we know that patients want more personalised care. The emergence of artificial intelligence (AI) has the potential to generate data that is tailored to the health needs of women and ultimately lead to better treatment options and outcomes. But the data insights generated by AI are only as good as the patients’ data available for analysis. To maximize the potential of AI—and meet the expectation of personalised care for patients—healthcare leaders need to be aware of who is and isn’t being included in studies and clinical trials, like women, and telegraph the need for greater inclusion to their teams.
These ideas are just the tip of the iceberg. Sure, we have come a long way since Elizabeth Blackwell—the first female physician in the United States—founded New York Presbyterian Hospital. Sure, there is still plenty of work to do, but I do hope my contribution is paving the way for more women to take on leadership roles in healthcare and make a positive impact on lives of all patients and their families.